Dentsply Sirona Tops Q2 EPS at $0.52 vs $0.36 Consensus and Affirms FY2026 Guidance
Question
Dentsply Sirona Tops Q2 EPS at $0.52 vs $0.36 Consensus and Affirms FY2026 Guidance
Direct answer
Dentsply Sirona delivered an earnings beat for Q2, generating adjusted EPS of $0.52 compared to analyst consensus of $0.36. Top-line revenue declined 4.1% year-over-year, reflecting broader volume headwinds in select dental equipment lines. Wellspect Healthcare provided an operational offset with 7.1% growth. Management maintained full-year 2026 guidance, reaffirming sales expectations of $3.5 billion to $3.6 billion and adjusted earnings per share between $1.40 and $1.50. — bullish pressure on XRAY.
- Original publisher
- Market Ontology
- Evidence through
- 2026-09-09
- Published
- 2026-10-20
- Revision
- 1 · 2026-10-20
Cite as: Market Ontology, “Dentsply Sirona Tops Q2 EPS at $0.52 vs $0.36 Consensus and Affirms FY2026 Guidance”, revision 1, evidence through 2026-09-09. https://marketontology.com/catalysts/2026-09-09/dentsply-sirona-tops-q2-eps-at-0-52-vs-0-36-consensus-and-affirms-fy2026-guidanc-78e552
| Asset | Direction | Timeframe | Channel | Score |
|---|---|---|---|---|
| XRAY | ▲Bull | 1–5 days | Catalyst Driven | 64 |
Dentsply Sirona Tops Q2 EPS at $0.52 vs $0.36 Consensus and Affirms FY2026 Guidance
Dentsply Sirona delivered an earnings beat for Q2, generating adjusted EPS of $0.52 compared to analyst consensus of $0.36. Top-line revenue declined 4.1% year-over-year, reflecting broader volume headwinds in select dental equipment lines. Wellspect Healthcare provided an operational offset with 7.1% growth. Management maintained full-year 2026 guidance, reaffirming sales expectations of $3.5 billion to $3.6 billion and adjusted earnings per share between $1.40 and $1.50. — bullish pressure on XRAY.
Dentsply Sirona delivered an earnings beat for Q2, generating adjusted EPS of $0.52 compared to analyst consensus of $0.36. Top-line revenue declined 4.1% year-over-year, reflecting broader volume headwinds in select dental equipment lines. Wellspect Healthcare provided an operational offset with 7.1% growth. Management maintained full-year 2026 guidance, reaffirming sales expectations of $3.5 billion to $3.6 billion and adjusted earnings per share between $1.40 and $1.50.
- SummaryDentsply Sirona delivered an earnings beat for Q2, generating adjusted EPS of $0.52 compared to analyst consensus of $0.36. Top-line revenue declined 4.1% year-over-year, reflecting broader volume headwinds in select dental equipment lines. Wellspect Healthcare provided an operational offset with 7.1% growth. Management maintained full-year 2026 guidance, reaffirming sales expectations of $3.5 billion to $3.6 billion and adjusted earnings per share between $1.40 and $1.50.
- XRAYDirect directional exposure
Illustrative, not advice
- Crowded positioning may already reflect the move
- Counter-catalyst could neutralize the thesis before window closes
- XRAY closes below pre-catalyst level on rising volume
- Catalyst narrative is officially walked back or contradicted
- Cross-asset confirmation (rates / FX / vol) reverses direction
- XRAY price vs. pre-event level
- XRAY volume vs. 20-day average
What happened next
| Asset | Call | Base close | +1 day | +5 days | +20 days |
|---|---|---|---|---|---|
| XRAY | Bullishdisagreed | 10.72 2026-09-09 | -2.05% | -5.41% | Pending |
Closing prices from stored daily bars; returns measured from the last close on or before the event date. Not a recommendation.
No verifiable public source recorded for this card.
Related catalysts
- 2026-09-09Dentsply Sirona Beats Q2 EPS at $0.52 vs $0.36 Consensus and Affirms FY26 OutlookALGN XRAY-5.41%
- 2026-09-09Dentsply Sirona Beats Q2 EPS at $0.52 and Affirms FY2026 Sales GuidanceALGN XRAY-5.41%
- 2026-09-09Dentsply Sirona Tops Q2 EPS at $0.52 vs $0.36 Consensus and Affirms FY2026 GuidanceALGN XRAY-5.41%
- 2026-09-09Dentsply Sirona Beats Q2 EPS Estimates at $0.52 and Reaffirms FY2026 TargetsXRAY-5.41%
- 2026-09-09Dentsply Sirona Beats Q2 EPS at $0.52 and Reaffirms FY26 Sales OutlookXRAY-5.41%
- 2026-09-09Dentsply Sirona reports Q2 adjusted EPS of $0.52 and maintains $3.5B-$3.6B sales outlookALGN XRAY-5.41%
- 2026-09-09Dentsply Sirona Q2 EPS Beats at $0.52 Despite 4.1% Revenue ContractionXRAY-5.41%
- 2026-09-09Dentsply Sirona Beats Q2 EPS at $0.52 and Reaffirms FY26 Sales OutlookXRAY-5.41%
See today's live cards
Public pages are published 24 hours after the product shows them. Desk shows every catalyst, event and causal reading as it happens, mapped to your holdings.